Selected article for: "eclipse phase and target cell"

Author: Antonio Gonçalves; Julie Bertrand; Ruian Ke; Emmanuelle Comets; Xavier de Lamballerie; Denis Malvy; Andrés Pizzorno; Olivier Terrier; Manuel Rosa Calatrava; France Mentré; Patrick Smith; Alan S Perelson; Jérémie Guedj
Title: Timing of antiviral treatment initiation is critical to reduce SARS-Cov-2 viral load
  • Document date: 2020_4_7
  • ID: n6l2804j_20
    Snippet: Here we used a "target-cell limited" model with an eclipse phase Fig S4 and Table S1 ). In influenza A, another respiratory 154 infectious disease, estimates of the within host R 0 varied greatly, but the half-life of infected 155 cells was shorter than 10 hours (see more details in [15]), suggesting a faster clearance of 156 influenza infected cells than SARS-CoV-2......
    Document: Here we used a "target-cell limited" model with an eclipse phase Fig S4 and Table S1 ). In influenza A, another respiratory 154 infectious disease, estimates of the within host R 0 varied greatly, but the half-life of infected 155 cells was shorter than 10 hours (see more details in [15]), suggesting a faster clearance of 156 influenza infected cells than SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • greatly vary and infectious disease: 1, 2, 3, 4, 5, 6
    • greatly vary and target cell: 1
    • infect cell and SARS infect cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • infect cell and target cell: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • infectious disease and limit model: 1, 2, 3, 4, 5
    • infectious disease and SARS infect cell: 1
    • infectious disease and target cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • SARS infect cell and target cell: 1, 2